植物誘導体医薬品市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00021201
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市場紹介 古来より、薬草としても知られる薬用植物が発見され、伝統医学の実践で使用されてきました。昆虫、菌類、病気、草食哺乳類から身を守るために、植物は何百もの化合物を合成します。生物学的活性の可能性がある、または確立されている植物化学物質が多数特定されています。 市場のダイナミクス 植物誘導体医薬品市場は、慢性疾患および感染症 (皮膚疾患、胃腸疾患) の有病率の増加、薬剤耐性の増加により牽引されています。さらに、技術の進歩により、植物由来医薬品メーカーに成長の機会がもたらされます。 市場範囲 「2031 年までの植物誘導体医薬品市場分析」は、世界市場の傾向分析に特に焦点を当てた、ヘルスケア業界の専門的かつ詳細な調査です。このレポートは、タイプ、治療用途、用量タイプ、エンドユーザー、流通チャネルごとに詳細な市場分割を行い、植物誘導体医薬品市場の概要を提供することを目的としています。植物誘導体医薬品市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、植物誘導体医薬品市場の主要プレーヤーの市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。 市場セグメンテーション 植物誘導体医薬品市場は、タイプ、治療用途、用量タイプ、エンドユーザー、流通チャネルに分割されています。種類に基づいて、市場はテルペン、ステロイド、配糖体、フェノール、その他に分類されます。治療アプリケーションに基づいて、市場は腫瘍学、皮膚科、中枢神経系疾患、感染症、心血管疾患、呼吸器疾患、その他に分類されます。投与量の種類に基づいて、市場は経口、液体、非経口に分類されます。エンドユーザーに基づいて、市場は病院、専門クリニック、在宅医療、その他として分類されます。流通チャネルに基づいて、市場は病院薬局、小売薬局、オンライン薬局として分類されます。 このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた植物誘導体医薬品市場の概要と予測を提供します。また、北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。各地域ごとの植物誘導体医薬品市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、需要と供給の両方の側面から植物誘導体医薬品市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートはまた、北米、ヨーロッパ、APAC、MEA、中南米の5つの地域すべてについて、これらの地域の植物誘導体医薬品市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後、徹底的なPEST分析を提供します。 市場関係者 レポートは、有機的および無機的な成長戦略としての植物誘導体医薬品市場の主要な発展をカバーしています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。植物誘導体医薬品市場の市場プレーヤーは、世界市場での植物誘導体医薬品市場の需要の高まりに伴い、将来的に有利な成長の機会があると予想されています。以下は、植物誘導体医薬品市場に従事するいくつかの企業のリストです。レポートには、SWOT分析と市場戦略とともに、植物誘導体医薬品市場の主要プレーヤーのプロフィールも含まれています。さらに、このレポートは、企業概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を含む業界の主要企業に焦点を当てています。
    • アボット研究所 • バイエル • ベーリンガーインゲルハイム • ブリストルマイヤーズ スクイブ • カーダックス・ファーマシューティカルズ •  CHONG KUN DANG PHARMACEUTICAL CORP. • 株式会社フィトケムプロダクツ • ガラパゴス ネバダ州 • グラクソスミスクライン •  GLENMARK PHARMACEUTICALS LIMITED
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供しています。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR in Plant Derivative Drugs Market?

The market is expected to register a CAGR of 8.7% during 2021–2031.

What are driving factors impacting the Plant Derivative Drugs Market?

The driving factors of the market are growing consumer preference for natural and plant-based treatments as an alternative to synthetic drugs, rising awareness of the therapeutic benefits of plant-derived compounds in treating various diseases, and advances in biotechnology which improve the extraction and manufacture of drugs from plants.

What are the future trends of Plant Derivative Drugs Market?

Key trends in the market include increased researches into less investigated plants for unused therapeutic potential, and growth in the market of herbal medicine, which incorporates more plant derivatives into mainstream pharmaceuticals.

Which are leading players in Plant Derivative Drugs Market?

Key companies in this market are- ABBOTT LABORATORIES, BAYER, BOEHRINGER INGELHEIM,BRISTOL-MYERS SQUIBB,CARDAX PHARMACEUTICALS, CHONG KUN DANG PHARMACEUTICAL CORP, FYTOKEM PRODUCTS INC., GALAPAGOS NV, GLAXOSMITHKLINE

What are the deliverable formats of the Plant Derivative Drugs Market?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. ABBOTT LABORATORIES
2. BAYER
3. BOEHRINGER INGELHEIM
4. BRISTOL-MYERS SQUIBB
5. CARDAX PHARMACEUTICALS
6. CHONG KUN DANG PHARMACEUTICAL CORP
7. FYTOKEM PRODUCTS INC.
8. GALAPAGOS NV
9. GLAXOSMITHKLINE
10. GLENMARK PHARMACEUTICALS LIMITED
11. Hsrx Biopharmaceutical
12. Indena
13. Izun Pharmaceuticals Corp.
14. Lupin Pharmaceuticals Inc.
15. Medigene Ag
16. Merck & Co. Inc.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.